- Home
- APRE vs NCPL Comparison
APRE vs NCPL Comparison
Compare APRE & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APRE | NCPL |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 5.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | APRE | NCPL |
|---|---|---|
| Price | $0.84 | $0.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 77.0K | ★ 1.6M |
| Earning Date | 11-12-2025 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $488,239.00 | ★ $797,839.00 |
| Revenue This Year | N/A | $739.37 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.83 | $0.61 |
| 52 Week High | $4.65 | $8.75 |
Technical Indicators
Market Signals| Indicator | APRE | NCPL |
|---|---|---|
| Relative Strength Index (RSI) | 33.19 | 44.48 |
| Support Level | $0.89 | $0.61 |
| Resistance Level | $0.91 | $0.89 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.99 | 49.59 |
Price Performance
Historical ComparisonAbout APRE Aprea Therapeutics Inc.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.